LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 229 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $57,829,000 | -23.5% | 440,802 | -11.1% | 0.84% | -26.7% |
Q1 2021 | $75,597,000 | +6.1% | 495,881 | -30.8% | 1.14% | +0.3% |
Q4 2020 | $71,250,000 | +5.4% | 716,440 | +1.0% | 1.14% | -16.7% |
Q3 2020 | $67,620,000 | -10.1% | 709,398 | +5.4% | 1.36% | -16.7% |
Q2 2020 | $75,249,000 | +59.5% | 672,768 | +3.7% | 1.64% | +18.7% |
Q1 2020 | $47,166,000 | -27.0% | 648,603 | +4.7% | 1.38% | -11.3% |
Q4 2019 | $64,624,000 | +2.6% | 619,653 | -2.1% | 1.56% | -3.5% |
Q3 2019 | $62,978,000 | -13.3% | 632,694 | -0.6% | 1.61% | -11.2% |
Q2 2019 | $72,679,000 | -6.9% | 636,699 | +2.5% | 1.82% | -16.4% |
Q1 2019 | $78,067,000 | +18.2% | 621,006 | +27.6% | 2.17% | +3.2% |
Q4 2018 | $66,063,000 | -57.5% | 486,833 | -14.0% | 2.10% | -46.9% |
Q3 2018 | $155,423,000 | +49.5% | 566,223 | +12.8% | 3.97% | +18.5% |
Q2 2018 | $103,977,000 | +33.8% | 501,894 | +6.7% | 3.35% | +12.5% |
Q1 2018 | $77,713,000 | +15.9% | 470,530 | -3.9% | 2.98% | +15.6% |
Q4 2017 | $67,072,000 | +13.7% | 489,830 | +13.1% | 2.58% | -1.3% |
Q3 2017 | $58,970,000 | +25.9% | 433,125 | +12.2% | 2.61% | +7.0% |
Q2 2017 | $46,844,000 | +22.7% | 385,869 | +7.0% | 2.44% | +5.6% |
Q1 2017 | $38,184,000 | +10.2% | 360,774 | +5.8% | 2.31% | +0.0% |
Q4 2016 | $34,651,000 | +0.0% | 341,022 | +0.5% | 2.31% | -2.8% |
Q3 2016 | $34,646,000 | -7.6% | 339,467 | +8.0% | 2.37% | -14.3% |
Q2 2016 | $37,480,000 | -15.3% | 314,247 | -24.0% | 2.77% | -7.4% |
Q1 2016 | $44,267,000 | +42.7% | 413,362 | +44.5% | 2.99% | +19.2% |
Q4 2015 | $31,026,000 | +17.3% | 286,162 | -7.3% | 2.51% | +18.3% |
Q3 2015 | $26,444,000 | -18.1% | 308,750 | -3.6% | 2.12% | -5.4% |
Q2 2015 | $32,302,000 | +28.7% | 320,141 | -1.6% | 2.24% | +30.5% |
Q1 2015 | $25,097,000 | +42.9% | 325,471 | -1.4% | 1.72% | +40.6% |
Q4 2014 | $17,563,000 | +27.5% | 330,066 | +12.6% | 1.22% | +21.5% |
Q3 2014 | $13,771,000 | -9.4% | 293,057 | +20.1% | 1.01% | -1.4% |
Q2 2014 | $15,197,000 | – | 243,967 | – | 1.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |